Blood pressure ACEi inhibitors increase Covid survival rates

Researchers have found that people who are on blood pressure medication can improve coronavirus survival rates by a third.

Scientific researchers discovered those who are at risk of getting a severe coronavirus infection and including death, are are less likely by a third if they are taking Angiotensin-Converting Enzyme inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB), for high blood pressure.

Lead researcher Dr Vassilios Vassiliou, from the University of East Anglia’s Norwich Medical School, said: “We know that patients with cardiovascular diseases are at particular risk of severe Covid-19 infection.

“But at the start of the pandemic, there was concern that specific medications for high blood pressure could be linked with worse outcomes for Covid-19 patients.

“We wanted to find out what the impact of these medications is for people with Covid-19.”